Item 7.01 Regulation FD Disclosure.

On or around March 9, 2023, CNL Healthcare Properties, Inc. (the "Company") sent a letter to its stockholders notifying them of the Company's estimated net asset value ("NAV") per share as of December 31, 2022 and related matters, and sent an e-mail correspondence to financial professionals notifying them of the same matters. A copy of the letter is filed as Exhibit 99.1 and a copy of the e-mail correspondence is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference solely for the purposes of this Item 7.01 disclosure.

Pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"), the information contained in this Item 7.01 disclosure, including Exhibits 99.1 and 99.2, is deemed to have been furnished and shall not be deemed to be "filed" under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall any of such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

By furnishing the information contained in this Item 7.01 disclosure, including Exhibits 99.1 and 99.2, the Company makes no admission as to the materiality of such information.




Item 8.01 Other Events.


Background and Conclusion

On March 8, 2023, the Board unanimously approved $6.92 per share as the Company's estimated NAV as of December 31, 2022 (the "2022 NAV"). The Company prepares and announces an estimated net asset value per share of its common stock and provides such information to its stockholders and to members of the Financial Industry Regulatory Authority ("FINRA") and their associated persons who participated in the Company's public offerings to assist them in meeting their customer account statement reporting obligations under National Association of Securities Dealers Conduct Rule 2340. For a summary of all of the Company's previously announced NAVs, please see "Historical NAVs" in this Current Report below.

To assist the Board and the Company's valuation committee, which is comprised solely of the Company's independent directors (the "Valuation Committee"), in establishing a new estimated NAV per share of the Company's common stock as of December 31, 2022 (the "Valuation Date"), the Company engaged Robert A. Stanger & Co., Inc., an independent third-party valuation firm ("Stanger"), to provide a net asset valuation analysis of the Company. Stanger developed a net asset valuation analysis of the Company and provided the analysis to the Valuation Committee in a report dated March 8, 2023 that contained, among other information, a range of per share net asset values for the Company's common stock as of the Valuation Date (the "Valuation Report").

The Valuation Committee and the Board reviewed the Valuation Report and considered the material assumptions and valuation methodologies applied and described therein. Upon due consideration, on March 8, 2023, the Valuation Committee determined that the range of per share values for the Company's common stock was reasonable as of the Valuation Date and recommended the Board approve $6.92 per share as the estimated NAV as of the Valuation Date. Thereafter, also on March 8, 2023, the Board accepted the recommendation of the Valuation Committee and unanimously approved $6.92 per share as the Company's estimated NAV as of the Valuation Date. The 2022 NAV is the midpoint of the range of per share net asset values, adjusted for estimated transaction costs, for the Company's common stock that Stanger provided in the Valuation Report.

--------------------------------------------------------------------------------

Other than the adjustment for estimated property-level transaction costs, the Board's determination of the 2022 NAV was undertaken in accordance with the Company's valuation policy and the recommendations and methodologies of the Institute for Portfolio Alternatives, a trade association for non-listed direct investment vehicles ("IPA"), as set forth in the Investment Program Association Practice Guideline 2013-01 "Valuations of Publicly Registered Non-Listed REITs" dated April 29, 2013 ("IPA Practice Guideline").

The 2022 NAV represents a snapshot in time as of December 31, 2022, will likely change, and does not represent the amount a stockholder would receive now or in the future for his or her shares of the Company's common stock. The 2022 NAV is based on a number of assumptions, estimates and data that are inherently imprecise and susceptible to uncertainty and changes in circumstances. Please see "Valuation Methodologies and Major Assumptions," "Valuation Summary," and "Additional Information Regarding the Valuation, Limitations of the 2022 NAV and Stanger" in this Current Report, below.

The Company will hold a webinar on March 21, 2023, at 2:30 p.m., Eastern Time, to review the 2022 NAV.

Valuation Methodologies and Major Assumptions

As of the Valuation Date, the Company's real estate portfolio consisted of interests in 70 properties, including 69 seniors housing communities and one vacant land parcel (the "Appraised Properties" or "Appraised Property"). The Appraised Properties were valued using valuation and appraisal methodologies consistent with real estate industry standards and practices, as described further below.

As of the Valuation Date, the aggregate estimated value of the Appraised Properties was approximately $1.77 billion. To estimate the value of the Appraised Properties, Stanger conducted an appraisal of each asset. In determining the value of each Appraised Property, Stanger utilized all information that it deemed relevant, including information from the Company's advisor CNL Healthcare Corp. (the "Advisor") and its own data sources, which data sources included trends in capitalization rates, leasing rates and other economic factors. In conducting its appraisals of the Appraised Properties, and pursuant to its engagement, Stanger utilized the income approach to valuation, which included a discounted cash flow ("DCF") analysis and/or direct capitalization analysis to determine value (other than the vacant land parcel). Stanger relied solely on DCF analyses in determining the appraised value of 54 RIDEA seniors housing properties and two leased properties. Stanger utilized direct capitalization analyses for 13 leased seniors housing properties and used a sales comparison approach for the land parcels (which includes one vacant land parcel and excess or surplus land) in the 2022 NAV. Stanger also considered impacts of the COVID-19 pandemic ("COVID-19") on the Appraised Properties.

For properties in which a DCF analysis was utilized, pro forma statements of operations for such properties including revenues, expenses and capital expenditures, were analyzed and projected over a multi-year period (typically ten years). Projected operating expenses in the DCF analysis included estimated COVID-19 related expenses. A reversion value is estimated after the holding period and then capitalized at an appropriate terminal capitalization rate reflecting the age and anticipated functional and economic obsolescence and competitive position of such properties to determine their reversion value. Net proceeds to owners are determined by deducting appropriate costs of sale in the reversion year. The discount rate selected for the DCF analysis is based upon estimated target rates of return for buyers of similar properties with consideration given to unique property-related factors, lease-up projections, location and age. The discount rate is then applied to the projected cash flows to derive a net present value.

The direct capitalization analysis was performed by applying a market capitalization rate for each applicable Appraised Property to the estimated stabilized forward-year annual net operating income at each such property. In selecting each capitalization rate, Stanger considered, among other factors, prevailing capitalization rates in the applicable property sector, the property's location, age and condition, the property's operating trends, the anticipated year of stabilization, the lease coverage ratios and other unique property factors.

As applicable, Stanger adjusted the capitalized value of each Appraised Property for any excess land, deferred maintenance or capital needs and lease-up costs to estimate the "as-is" value of each Appraised Property as of the Valuation Date. Stanger then adjusted the "as-is" property values, as appropriate, for the Company's allocable ownership interest in the Appraised Properties to account for the interest of any third-party investment partners, including any priority distributions.

--------------------------------------------------------------------------------

In providing a valuation for the land parcels owned by the Company (which includes the one vacant land parcel and excess or surplus land parcels deemed contributory in value within five seniors communities) that are part of the Appraised Properties, actual and/or proposed land sale transactions were identified in each property's market or region and adjusted to reflect, as appropriate: (i) the property rights conveyed in such transaction; (ii) any extraordinary, special or non-market financing or credits provided by the seller or others which may have influenced the sale price; (iii) adjustments for non-arms-length sale transactions; (iv) improvements or deterioration of market conditions from the reported land sale date through the Valuation Date; (v) listing status versus a consummated sale; (vi) location factors such as area demographics, traffic exposure and access; (vii) land deemed surplus; (vii) zoning factors; and (ix) land size. An index of value (price per square foot) for each land parcel from the land sale comparables was derived and the appropriate index was applied to the Company's land and excess or surplus land parcels.

Debt: The Company determined the fair market value of its debt liabilities by applying a discounted cash flow analysis over the projected remaining term of each debt liability and reflecting the debt's contractual agreement and corresponding interest and principal payments. The expected debt payments were then discounted to present value at an interest rate the Company deemed appropriate and reflective of market interest rates as of the Valuation Date for debt instruments with similar collateral, anticipated duration and prepayment terms. While Stanger did not determine the value of the Company's debt liabilities, Stanger did review the market interest rates used by the Company in determining the debt fair market value and, based upon a summary of the loan terms as provided by the Company, determined that in the aggregate, the market interest rates utilized by the Company were reasonable.

Cash, Other Tangible Assets and Other Liabilities: The fair value of the Company's cash, other tangible assets and liabilities was estimated by the Company to approximate net realizable value as of the Valuation Date based upon the values of these assets and liabilities on the Company's balance sheet, and Stanger reviewed and relied upon and utilized such amounts in its Valuation Report.

Stanger prepared an appraisal report (the "Appraisal Report") summarizing key information and assumptions and provided an appraised value on the Appraised Properties in which the Company owned an interest as of the Valuation Date. In accordance with the valuation policy and the IPA Practice Guideline, the appraised value excludes any portfolio premium. The Valuation Report incorporates the appraised value conclusions of the Appraisal Report adjusted for any interests held by third parties in the Appraised Properties. Furthermore, the Valuation Report includes (i) the Company's fair market value of its debt liabilities; (ii) cash and other tangible assets and liabilities based upon their current net realizable value; (iii) the Advisor's deductions for estimated property-level transaction costs in a hypothetical orderly sale of the real estate assets of the Company as of the Valuation Date; and (iv) Stanger's estimate of the Advisor's subordinated participation in net sales proceeds or incentive fee due upon liquidation of the Company's portfolio (of which there was none).

Valuation Summary



The following is a summary of the direct capitalization rates, discount rates
and terminal capitalization rates used to arrive at the value of the Appraised
Properties:

                                    2022 Range
                                 Min          Max         W. Avg (a)
RIDEA
Direct Capitalization Rate                   Not Utilized
Discount Rate                     7.50 %       9.50 %            8.48 %
Terminal Capitalization Rate      6.25 %       8.00 %            7.04 %

NNN Leased
Direct Capitalization Rate        7.00 %       7.50 %            7.33 %
Discount Rate                    10.25 %      11.25 %           10.74 %
Terminal Capitalization Rate      8.50 %       9.25 %            8.87 %


(a) The weighted average capitalization rate, discount rates and terminal

capitalization rates are weighted on stabilized net operating income.

--------------------------------------------------------------------------------

In comparison to last year's valuation, the comparable set of RIDEA properties had an increase in the weighted average discount rate of 44 basis points, to 8.48%, and an increase in the terminal capitalization rate of 9 basis points, to 7.04% in the DCF analyses. The two triple-net leased properties that also utilized DCF had an increase in the weighted average discount rate of 56 basis points, to 10.74%, and a decline in the terminal capitalization rate of 31 basis points, to 8.87%. The thirteen triple-net leased properties utilizing direct cap analyses had an increase in the weighted average direct capitalization rate of 25 basis points, to 7.33%.

The Valuation Report contained a range for the Company's estimated 2022 NAV of $6.57 to $7.30 per share, including deductions for transaction costs estimated by the Advisor in a hypothetical orderly sale of the assets of the Company, based on a share count of approximately 173.96 million shares issued and outstanding as of the Valuation Date, excluding restricted shares issued to the Company's Advisor in connection with the Expense Support and Restricted Stock Agreement between the Company and the Advisor, as amended from time to time. Such shares were excluded from the 2022 NAV calculation because the Company and the Advisor do not anticipate the vesting of those shares based on the terms and conditions set forth in the Expense Support and Restricted Stock Agreement.

The valuation range was calculated by varying the direct capitalization rates, discount rates and terminal capitalization rates by 25 basis points in either direction. Stanger also varied the price per square foot value for the one undeveloped land parcel by $0.25 in each direction. The lower end of the capitalization rate and discount rate range, and upper end of the land price per square foot range, has a positive $0.38 impact on NAV per share. The high end of the capitalization rate and discount range, and lower end of the land price per . . .

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.



99.1      Text of correspondence from the Company to Stockholders regarding the
        2022 NAV.

99.2      Text of correspondence from the Company to Financial Professionals
        regarding the 2022 NAV.

104     Cover Page Interactive Data File (embedded within the Inline XBRL
        document)

Caution Concerning Forward-Looking Statements

Statements in this Current Report on Form 8-K that are not statements of historical fact, including statements about the purported value of the Company's common stock, constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements that do not relate strictly to historical or current facts, but reflect management's current understandings, intentions, beliefs, plans, expectations, assumptions and/or predictions regarding the future of the Company's business and its performance, statements of future economic performance, and other future conditions and forecasts of future events and circumstances. Forward-looking statements are typically identified by words such as "believes," "expects," "anticipates," "intends," "estimates," "plans," "continues," "pro forma," "may," "will," "seeks," "should" and "could," and words and terms of similar substance in connection with discussions of future operating or financial performance, business strategy and portfolios, projected growth prospects, cash flows, costs and financing needs, legal proceedings, amount and timing of anticipated future distributions, estimated per share value of the Company's common stock, and other matters. The Company's forward-looking statements are not guarantees of future performance. While the Company's management believes its forward-looking statements are reasonable, such statements are inherently susceptible to uncertainty and changes in circumstances. As with any projection or forecast, forward-looking statements are necessarily dependent on assumptions, data and/or methods that may be incorrect or imprecise and may not be realized. The Company's forward-looking statements are based on management's current expectations and a variety of risks, uncertainties and other factors, many of which are beyond the Company's inability to control or accurately predict. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, the Company's actual results could differ materially from those set forth in the forward-looking statements due to a variety of risks, uncertainties and other factors.

For further information regarding risks and uncertainties associated with the Company's business, and important factors that could cause the Company's actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described under "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the "Risk Factors" sections of the Company's documents filed from time to time with the Securities and Exchange Commission, including, but not limited to, the Company's quarterly reports on Form 10-Q, and the Company's annual report on Form 10-K, copies of which may be obtained from the Company's website at http://www.cnlhealthcareproperties.com.

All written and oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by these cautionary statements. Forward-looking statements speak only as of the date on which they are made; the Company undertakes no obligation to, and expressly disclaims any obligation to, update or revise its forward-looking statements to reflect new information, changed assumptions, the occurrence of subsequent events, or changes to future operating results over time unless otherwise required by law.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses